Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Codexis

Biotech & Life Sciences · Redwood City, United States · Founded 2002 · IPO 2010 Thoroughbred

Biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics

Valuation
$250M
Market cap · May/2026
Revenue
$70M
Latest reported FY

Investors

5 investors on Codexis's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 5 investors entered at this stage
CMEA Capital
Bio*One Capital
Maxygen
Chevron Technology Ventures
EDBI

Global footprint

Where Codexis has talent and traffic

AI talent share
0.4% of workforce is AI talent
(1 of 242 staff)
Core AI10.41%
Other AI00%
Non-AI workforce24199.59%
Workforce by country
7 countries with
team presence
🇺🇸 United States94.5%
🇸🇬 Singapore1.8%
🇭🇺 Hungary1.2%
🇫🇷 France0.6%
🇨🇭 Switzerland0.6%
Top 5 of 7 shown
Web traffic by country
13K monthly visits
across markets
🇺🇸 United States55.4%
🇨🇦 Canada10.8%
🇬🇧 United Kingdom10.8%
🇮🇳 India10%
🇯🇵 Japan6.9%
Top 5 markets shown

Capital deployed

Codexis's 3 investments and acquisitions.

Every disclosed deal where Codexis appeared as a backer or acquirer, 2021–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Codexis's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Codexis's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Codexis

        An AI-synthesized read of the highest-engagement posts about Codexis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Codexis on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.